PAPER Gomez JM, Aguilar M, Soler J
SEARCH RESULTS
345052 RESULTS
PAPER Wirths O, Weickert S, Majtenyi K, Havas L, Kahle PJ, Okochi M, Haass C, Multhaup G, Beyreuther K, Bayer TA
Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.
Neuroreport. 2000 Nov 27;11(17):3737-41. PubMed.PAPER Moore D, Iritani S, Chambers J, Emson P
Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease.
Neuroreport. 2000 Nov 27;11(17):3799-803. PubMed.PAPER Montine TJ, Shinobu L, Montine KS, Roberts LJ, Kowall NW, Beal MF, Morrow JD
No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls.
Ann Neurol. 2000 Dec;48(6):950. PubMed.PAPER Cappa A, Calcagni ML, Villa G, Giordano A, Marra C, De Rossi G, Puopolo M, Gainotti G
Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):22-7. PubMed.PAPER Lin WR, Wozniak MA, Esiri MM, Klenerman P, Itzhaki RF
Herpes simplex encephalitis: involvement of apolipoprotein E genotype.
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):117-9. PubMed.PAPER Thorpe JR, Morley SJ, Rulten SL
Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
J Histochem Cytochem. 2001 Jan;49(1):97-108. PubMed.PAPER Schroeter H, Williams RJ, Matin R, Iversen L, Rice-Evans CA
Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein.
Free Radic Biol Med. 2000 Dec 15;29(12):1222-33. PubMed.PAPER Bartolucci C, Perola E, Pilger C, Fels G, Lamba D
Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs.
Proteins. 2001 Feb 1;42(2):182-91. PubMed.PAPER Massi F, Straub JE
Energy landscape theory for Alzheimer's amyloid beta-peptide fibril elongation.
Proteins. 2001 Feb 1;42(2):217-29. PubMed.PAPER Mattson MP
Neuroprotective signaling and the aging brain: take away my food and let me run.
Brain Res. 2000 Dec 15;886(1-2):47-53. PubMed.PAPER Neve RL, McPhie DL, Chen Y
Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
Brain Res. 2000 Dec 15;886(1-2):54-66. PubMed.PAPER Kumar A
Alzheimer's disease: amyloid beta-peptide antibody vaccine as plaque remover.
J Biosci. 2000 Dec;25(4):315-6. PubMed.PAPER Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.
J Clin Invest. 2000 Dec;106(12):1489-99. PubMed.PAPER Shanavas A, Papasozomenos SC
tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14139-44. PubMed.Current Filters
No filters selected